Novel small - molecule therapies
搜索文档
Cogent Biosciences (NasdaqGS:COGT) 2025 Conference Transcript
2025-11-19 20:32
Cogent Biosciences (NasdaqGS:COGT) 2025 Conference November 19, 2025 06:30 AM ET Company ParticipantsAndrew Robbins - CEOConference Call ParticipantsClara Dong - Biotech AnalystClara DongAll right, good morning. Thanks, everybody, for joining Jefferies Healthcare Conference in London. My name is Clara, and I'm one of the biotech analysts here at Jefferies. Here, it's my pleasure to welcome the Chief Executive Officer, Andy Robbins, from Cogent Biosciences. It's been a really exciting year for Cogent, so I'l ...